Ultrasound-guided compared to conventional treatment in gestational diabetes leads to improved birthweight but more insulin treatment: Systematic review and meta-analysis

Acta Obstetricia et Gynecologica Scandinavica

Volumn 93, Issue 2, 2014, Pages 144-151

  Balsells, Montserrat ^a   García Patterson, Apolonia ^b   Gich, Ignasi ^b,c   Corcoy, Rosa ^b,c,d  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Gestational diabetes mellitus; insulin therapy; meta analysis; randomized control trial; systematic review; ultrasound

Indexed keywords

INSULIN;

BIRTH WEIGHT; FEMALE; FETUS ECHOGRAPHY; FETUS GROWTH; FETUS OUTCOME; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; INTERMETHOD COMPARISON; LARGE FOR GESTATIONAL AGE; MACROSOMIA; META ANALYSIS; PERINATAL PERIOD; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMALL FOR DATE INFANT; SYSTEMATIC REVIEW;

GESTATIONAL DIABETES MELLITUS; INSULIN THERAPY; META-ANALYSIS; RANDOMIZED CONTROL TRIAL; SYSTEMATIC REVIEW; ULTRASOUND;

BIRTH WEIGHT; DIABETES, GESTATIONAL; FEMALE; FETAL DEVELOPMENT; FETAL MACROSOMIA; HUMANS; INSULIN; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY, PRENATAL;

EID: 84892824428     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12291     Document Type: Review

References (20)

1. Metzger BE, Buchanam TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the 5th International Workshop Conference on gestational diabetes mellitus. Diabetes Care. 2007; 30 (Suppl 2): S251-60.
2. National Institute of Clinical Excellence. Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. London: NICE, 2008. Available online at: http://www.nice.org.uk/CG063 (accessed 29 April, 2012).
3. Buchanan TA, Kjos SL, Montoro M, Wu PY, Madrilejo NG, Gonzalez M, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care. 1994; 17: 275-83.
4. Kjos SL, Schaefer-Graf U, Sardesi S, Peters RK, Buley A, Xiang AH, et al. A randomized controlled trial utilizing glycemic plus fetal ultrasound parameters vs glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care. 2001; 24: 1904-10.
5. Schaefer-Graf UM, Kjos SL, Fauzan OH, Bühling KJ, Siebert G, Bührer C, et al. A randomized trial evaluating the utility of a predominately fetal-growth based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care. 2004; 27: 297-302.
6. Bonomo M, Cetin I, Pisoni MP, Faden D, Mion E, Taricco E, et al. Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial. Diabetes Metab. 2004; 30: 237-43.
7. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009; 62: e1-34.
8. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340: c869.
9. SIGN risk calculator. Available online at: http://www.sign.ac.uk/ methodology/index.html (accessed 28 September, 2011).
10. Rossi G, Somigliana E, Moschetta M, Bottani B, Barbieri M, Vignali M,. Adequate timing of fetal ultrasound to guide metabolic therapy in mild gestational diabetes mellitus. Results from a randomized study. Acta Obstet Gynecol Scand. 2000; 79: 649-54.
11. Kjos SL, Schaefer-Graf UM,. Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select strict versus relaxed maternal glycemic targets. Diabetes Care. 2007; 30 (Suppl 2): S200-5.
12. Jacqueminet S, Jannot-Lamotte MF,. Therapeutic management of gestational diabetes. Diabetes Metab. 2010; 36: 658-71.
13. Thiebaugeorges O, Guyard-Boileau B,. Obstetrical care in gestational diabetes and management of preterm labour. Diabetes Metab. 2010; 36: 672-81.
14. Sacks DA,. The use of pharmacotherapy in pregnancies with suspected diabetic fetopathy. J Matern Fetal Neonatal Med. 2012; 25: 45-9.
15. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study group recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33: 676-82.
16. Houshmand A, Jensen DM, Mathiesen ER, Damm P,. Evolution of diagnostic criteria for gestational diabetes mellitus. Acta Obstet Gynecol Scand. 2013; 92: 739-45.
17. Corcoy R, Lumbreras B, Bartha JL, Ricart W, Grupo Español de Diabetes y Embarazo. New diagnostic criteria for gestational diabetes mellitus after the HAPO study. Are they valid in our environment? Endocrinol Nutr. 2010; 57: 277-80.
18. SIGN 116. Management of diabetes. A national clinical guideline. Available online at: http://www.sign.ac.uk (accessed 30 March, 2010).
19. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, For the ACHOIS Trial Group. Effect of treatment of gestational diabetes mellitus in pregnancy outcomes. N Engl J Med. 2005; 352: 2477-86.
20. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009; 361: 1339-48.